These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10052330)

  • 1. Signal transduction 2000.
    Nat Biotechnol; 1999 Feb; 17(2):111. PubMed ID: 10052330
    [No Abstract]   [Full Text] [Related]  

  • 2. Signal transduction as a drug-discovery platform.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT37-9. PubMed ID: 11221714
    [No Abstract]   [Full Text] [Related]  

  • 3. In the market-place.
    Gershon D
    Nature; 2004 Nov; 432(7014):243-5. PubMed ID: 15538372
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology overview: where the industry is heading.
    Rothman E
    Healthspan; 1987 Oct; 4(9):19-24. PubMed ID: 10284965
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotechnology. A drug industry revolution.
    Wagner M
    Mod Healthc; 1988 Apr; 18(18):32-4, 37. PubMed ID: 10287262
    [No Abstract]   [Full Text] [Related]  

  • 6. Premier funds biotechnology.
    Scott L
    Mod Healthc; 1996 Apr; 26(18):50. PubMed ID: 10157168
    [No Abstract]   [Full Text] [Related]  

  • 7. Redefining priorities in gene-based drug discovery.
    Khodadoust MM; Klein TP
    Nat Biotechnol; 2001 Aug; 19(8):707. PubMed ID: 11479549
    [No Abstract]   [Full Text] [Related]  

  • 8. BIO 2006 Annual International Convention. The current state of the global biotechnology industry.
    Zarkowska T
    IDrugs; 2006 Jun; 9(6):381-2. PubMed ID: 16752301
    [No Abstract]   [Full Text] [Related]  

  • 9. The biotechnology sector's craving for commercial expertise is fuelling a cultural exchange with drug industry.
    Smaglik P; Frantz S
    Nature; 2003 Apr; 422(6931):542-3. PubMed ID: 12673255
    [No Abstract]   [Full Text] [Related]  

  • 10. Sugen's strategy: a signal for P&U purchase.
    Glaser V
    Nat Biotechnol; 1999 Aug; 17(8):745-6. PubMed ID: 10429230
    [No Abstract]   [Full Text] [Related]  

  • 11. The biotechnology industry: What's next?
    Guertin PA
    Biotechnol J; 2009 Aug; 4(8):1124-31. PubMed ID: 19685466
    [No Abstract]   [Full Text] [Related]  

  • 12. The biotechnology industry organization's view on Hatch-Waxman reform.
    Schmickel D
    Food Drug Law J; 1999; 54(2):241-2. PubMed ID: 11758580
    [No Abstract]   [Full Text] [Related]  

  • 13. Company pushes broad-ranging patent claim.
    Ready T
    Nat Med; 2002 Oct; 8(10):1048. PubMed ID: 12357223
    [No Abstract]   [Full Text] [Related]  

  • 14. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 15. Biomanufacturing: a high-growth industry for North Carolina.
    Hartl B
    Drug Discov Today; 2005 Nov; 10(22):1494-7. PubMed ID: 16257370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AchemAsia 2007 announcement: China's biotechnology industry on the upswing.
    Biotechnol J; 2007 Mar; 2(3):288-90. PubMed ID: 17354215
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 18. Consider post-doctoral training in industry.
    Wong GH
    Nat Biotechnol; 2005 Jan; 23(1):151-2. PubMed ID: 15637634
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology. Drug firms wary of health bill.
    Wagner M
    Mod Healthc; 1988 Apr; 18(18):42. PubMed ID: 10287265
    [No Abstract]   [Full Text] [Related]  

  • 20. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.